NEW EVENTS - COMING SOON

PAST EVENTS

Read media coverage on Funding Biopharma, a symposium presented by Yankee Public Relations on June 9, 2009, by clicking the links below.

Life Science Leaders Discuss Financial Crisis	NJ Biotechs Work to Stay Viable as Industry Withers	Investor Relations Key to Raising Capital
FUNDING BIOPHARMA: Investor Strategies	Biotechs Seek Recession Beating Strategies	Finding Answers to the Biopharma Funding Crisis
Biotech Firms Learn Lessons in Navigating Troubled Times	Life Science Leaders to Discuss Finding Investors	Click Here to See Our Online Photo Album for Funding Biopharma

Biopharmaceutical companies around the country have been crushed by the meltdown of the financial markets. Record numbers of companies have failed as available funding has been cut dramatically, jeopardizing research and technology that could impact thousands of lives. Now, more than ever, biotechs need to find ways to influence potential investors and the public.

Leading experts in the biopharmaceutical industry will provide small and mid-sized biotechs with strategies for success in the present financial crisis. Biotech executives at public and private companies will share their experience, lessons learned and strategies for attracting investors. Representatives of the investment community will provide insights on the current marketplace and keys to funding opportunities. Industry leaders will discuss communications and regulatory stratgies designed to maximize profitability.

The symposium is intended for senior-level executives and managers in finance, corporate communications, investor relations and business development from both private and public life sciences companies in addition to experts in banking and financial services. Following are program details and links to panelist profiles.

Panel I: Insights from Biotech Executives

Perspectives from biotech executives on funding their companies. How did they gain investor support without losing control of the science that drives their organization? What are the lessons they learned? What advice can they offer?

Panelists

Annarie Lyles, Ph.D. Genmab - Senior Vice President, Head of Business Development	Ellen McDonald, M.B.A. Regado Biosciences - Senior Vice President, Business Operations & Chief Business Officer
Andrew Reaume, Ph.D., M.B.A. Melior Discovery - President/CEO & Co-Founder	Evan Myrianthopoulos DOR BioPharma - Chief Financial Officer and Senior Vice President

Panel II: What Do Investors Want to Hear?

Many biotechs have good stories to tell investors and the public in general, but lack the focus to communicate what their science really means. How do you bring science to life for investors? What are the key messages to communicate? What are the particular challenges of the current marketplace?

Panelists

Jeffrey H. Nicholas, J.D. Fox Rothschild - Partner/Chair of Technology, Venture Finance and Securities	John Pennett, C.P.A. Amper, Politziner & Mattia - Partner/Director of Life Science Practice
Avjit Roy, Ph.D. Five Prime Advisors - Director	Emilio Ragosa, J.D. Morgan Lewis - Partner in Business Finance

Gene Detroyer
Five Prime Advisors - Director

Panel III: Regulation and Profitability

What are the key elements of a regulatory strategy designed to maximize product profitability? What are the regulatory limitations and requirements when communicating with investors?

Panelists

Mike Page United Biosource Corporation - Senior Director of Regulatory Affairs	Linda Pissott Reig, J.D. Porzio, Bromberg & Newman - Principal
Nigel Smart, Ph.D. Smart Consulting Group - Managing Partner	Vincent A. Vietti, J.D. Fox Rothschild - Partner

Moderator

Fred Feiner
Yankee Public Relations - President





Exclusive Media Sponsor of Funding Biopharma

© 2009 Yankee public relations LLC